{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:42:13Z","timestamp":1791380533047,"version":"4.3.3"},"reference-count":32,"publisher":"MedWorks Media","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Background\nGiven the importance of medication adherence among individuals with bipolar disorder (BD), this analysis from an ongoing randomized controlled trial (RCT) examined the relationship between BD symptoms, functioning and adherence in 69 poorly adherent adults with BD.\nMethod\nStudy inclusion criteria included being \u2265 18 years old with BD Type 1 or 2, difficulties with medication adherence and actively symptomatic as measured by Brief Psychiatric Rating Scale (BPRS) score \u2265 36, Young Mania Rating Scale (YMRS) &gt; 8 or Montgomery Asberg Depression Rating Scale (MADRS) &gt; 8. Adherence was measured in 2 ways: 1) the self-reported Tablets Routine Questionnaire (TRQ) and 2) electronic pill container monitoring (eCap pillbox). BD symptoms and functioning were measured with the MADRS, YMRS, Clinical Global Impressions Scale (CGI), and Global Assessment of Functioning (GAF). Only screening and baseline data were examined.\nResults\nMean age was 42.32 (SD = 12.99) years, with 72.46% (n = 50) female and 43.48% (n = 30) non-white. Mean past 7-day percentage of days with missed BD medications using TRQ was 40.63% (SD = 32.61) and 30.30% (SD = 30.41) at screening and baseline, respectively. Baseline adherence using eCap was 42.16% (SD = 35.85) in those with available eCap data (n = 41). Worse adherence based on TRQ was significantly associated with higher MADRS (p = 0.04) and CGI (p = .03) but lower GAF (p = 0.02). eCAP measured adherence was not significantly associated with clinical variables.\nConclusion\nWhile depression and functioning were approximate markers of adherence, reliance on patient self-report or BD symptom presentation may give an incomplete picture of medication-taking behaviors.<\/jats:p>","DOI":"10.64719\/pb.4494","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:16Z","timestamp":1761046756000},"page":"60-72","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges"],"prefix":"10.64719","volume":"54","author":[{"given":"Martha","family":"Sajatovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farren","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Adeniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Weise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fiorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Yala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Lesanpezeshki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Einstadter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Lintunen J, L\u00e4hteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder\u2013A nationwide cohort study. J Affect Disord. 2023;333:403\u2013408. doi: 10.1016\/j.jad.2023.04.030. doi:","DOI":"10.1016\/j.jad.2023.04.030"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Jawad I, Watson S, Haddad PM, Talbot PS, McAllister-Williams RH. Medication nonadherence in bipolar disorder: A narrative review. Ther Adv Psychopharmacol. 2018;8(12):349\u2013363. doi: 10.1177\/2045125318804364. doi:","DOI":"10.1177\/2045125318804364"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders. 2006;8(3):232\u2013241. doi: 10.1111\/j.1399-5618.2006.00314.x. Research Support, N.I.H., Extramural. doi:","DOI":"10.1111\/j.1399-5618.2006.00314.x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatric Services. 2007;58(6):855\u2013863. doi: 10.1176\/appi.ps.58.6.855. Research Support, N.I.H., Extramural Research Support, U.S. Gov\u2019t, Non-P.H.S. doi:","DOI":"10.1176\/appi.ps.58.6.855"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta psychiatrica Scandinavica. 2002;105(3):164\u2013172.","DOI":"10.1034\/j.1600-0447.2002.1r084.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Perlick DA, Rosenheck RA, Clarkin JF et al. Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. Psychiatric Services. 2004;55(9):1029\u20131035. doi: 10.1176\/appi.ps.55.9.1029. doi:","DOI":"10.1176\/appi.ps.55.9.1029"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Gonzalez-Pinto A, Mosquera F, Alonso M et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disorders. 2006;8(5 Pt 2):618\u2013624. doi: 10.1111\/j.1399-5618.2006.00368.x. doi:","DOI":"10.1111\/j.1399-5618.2006.00368.x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Mason M, Cho Y, Rayo J, Gong Y, Harris M, Jiang Y. Technologies for medication adherence monitoring and technology assessment criteria: Narrative review. JMIR Mhealth Uhealth. 2022;10(3):e35157. doi: 10.2196\/35157. doi:","DOI":"10.2196\/35157"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Cohen B, Sixsmith A, Pollock Star A, Haglili O, O\u2019Rourke N. Direct and indirect predictors of medication adherence with bipolar disorder: Path analysis. JMIR Form Res. 2023;7:e44059. doi: 10.2196\/44059. doi:","DOI":"10.2196\/44059"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Levin JB, Briggs F, Blixen C et al. A randomized controlled trial of customized adherence enhancement (CAE-E): Study protocol for a hybrid effectiveness-implementation project. Trials. 2022;23(1):634. doi: 10.1186\/s13063-022-06517-0. doi:","DOI":"10.1186\/s13063-022-06517-0"},{"key":"ref11","unstructured":"First MB, Williams JBW, Karg RS, Spitzer RL. Structured clinical interview for DSM-5\u2014research version (SCID-5 for DSM-5, research version; SCID-5-RV) Arlington, VA: American Psychiatric Association; 2015."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Young RC, Biggs JT, Zeigler VE, Meyer DA. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry Suppl. 1978;133:429\u2013435.","DOI":"10.1192\/bjp.133.5.429"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. The British Journal of Psychiatry: The Journal of Mental Science. 1979;134:382\u2013389.","DOI":"10.1192\/bjp.134.4.382"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports. 1962;10:799\u2013812.","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Guy W. Clinical Global Impressions. ECDEU Assessment Manual for psychoparmacology. 1976 US Department of Health, Education, and Welfare (DHEW)","DOI":"10.1037\/e591322011-001"},{"key":"ref16","unstructured":"Spitzer RL, Gibbon M, Williams JBW. Global Assessment of Functioning (GAF) Scale. 1996 Outcome Assessment in Clinical Practice 1st ed. Williams and Wilkins."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson\u2019s disease. International Journal of Geriatric Psychiatry. 2000;15(7):644\u2013649.","DOI":"10.1002\/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Overall JA GD. The brief psychiatric rating scale. Psychological Reports. 1962;10:799\u2013812.","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of brief psychiatric rating scale scores. The British Journal of Psychiatry: The Journal of Mental Science. 2005;187:366\u2013371. doi: 10.1192\/bjp.187.4.366. doi:","DOI":"10.1192\/bjp.187.4.366"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF) The British Journal of Psychiatry: The Journal of Mental Science. 1995;166(5):654\u2013659.","DOI":"10.1192\/bjp.166.5.654"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. The American Journal of Psychiatry. 2002;159(11):1927\u20131929. doi: 10.1176\/appi.ajp.159.11.1927. doi:","DOI":"10.1176\/appi.ajp.159.11.1927"},{"key":"ref22","unstructured":"Corporation IM. eCAP\u2026the smart cap that enhances medication adherence. http:\/\/www.informationmediary.com\/ecap."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ayoade A, Oladipo I. Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy. Blood Press. 2012;21(3):161\u2013166. doi: 10.3109\/08037051.2012.679029. doi:","DOI":"10.3109\/08037051.2012.679029"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Merikangas KR, Jin R, He JP et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241\u2013251. doi: 10.1001\/archgenpsychiatry.2011.12. doi:","DOI":"10.1001\/archgenpsychiatry.2011.12"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Fagiolini A, Forgione R, Maccari M et al. Prevalence, chronicity, burden and borders of bipolar disorder. J Affect Disord. 2013;148(2\u20133):161\u2013169. doi: 10.1016\/j.jad.2013.02.001. doi:","DOI":"10.1016\/j.jad.2013.02.001"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Forte A, Baldessarini RJ, Tondo L, V\u00e1zquez GH, Pompili M, Girardi P. Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders. J Affect Disord. 2015;178:71\u201378. doi: 10.1016\/j.jad.2015.02.011. doi:","DOI":"10.1016\/j.jad.2015.02.011"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Youn H, Lee MS, Jeong HG, Kim SH. Evaluation of factors associated with medication adherence in patients with bipolar disorder using a medication event monitoring system: A 6-month follow-up prospective study. Annals of General Psychiatry. 2022;21(1):33. doi: 10.1186\/s12991-022-00411-4. doi:","DOI":"10.1186\/s12991-022-00411-4"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Basit SA, Mathews N, Kunik ME. Telemedicine interventions for medication adherence in mental illness: A systematic review. Gen Hosp Psychiatry. 2020;62:28\u201336. doi: 10.1016\/j.genhosppsych.2019.11.004. doi:","DOI":"10.1016\/j.genhosppsych.2019.11.004"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Belzeaux R, Correard N, Boyer L et al. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: Results from the FACE-BD cohort. J Affect Disord. 2013;151(3):1009\u20131015. doi: 10.1016\/j.jad.2013.08.028. doi:","DOI":"10.1016\/j.jad.2013.08.028"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Nsengiyumva NP, Mappin-Kasirer B, Oxlade O, Bastos M, Trajman A, Falzon D, Schwartzman K. Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support. Eur Respir J. 2018;52(5):1801363. doi: 10.1183\/13993003.01363-2018. doi: PMID: 30166325; PMCID: PMC6214576.","DOI":"10.1183\/13993003.01363-2018"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Thakkar D, Piparva KG, Lakkad SG. A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India. 2019;36(2):108\u2013111. doi: 10.4103\/lungindia.lungindia_86_18. doi:","DOI":"10.4103\/lungindia.lungindia_86_18"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"DiStefano MJ, Schmidt H. mHealth for tuberculosis treatment adherence: A Framework to guide ethical planning, implementation, and evaluation. Glob Health Sci Pract. 2016;4(2):211\u2013221. doi: 10.9745\/GHSP-D-16-00018. doi:","DOI":"10.9745\/GHSP-D-16-00018"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:32:37Z","timestamp":1791315157000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/association-between-symptom-severity-and-medication-adherence-in-adults-with-bipolar-disorder-reporting-adherence-challenges\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4494","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}